REDHILL BIOPHARMA LTD's ticker is and the CUSIP is 757468953. A total of 1 filers reported holding REDHILL BIOPHARMA LTD in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $351 | -94.2% | 2,500 | -79.0% | 0.00% | – |
| Q3 2022 | $6,000 | -40.0% | 11,900 | -0.8% | 0.00% | – |
| Q2 2022 | $10,000 | -67.7% | 12,000 | -2.4% | 0.00% | – |
| Q1 2022 | $31,000 | -66.3% | 12,300 | -65.5% | 0.00% | – |
| Q4 2021 | $92,000 | -72.9% | 35,700 | -51.8% | 0.00% | – |
| Q3 2021 | $339,000 | +551.9% | 74,100 | +888.0% | 0.00% | – |
| Q2 2021 | $52,000 | -58.4% | 7,500 | -56.1% | 0.00% | – |
| Q1 2021 | $125,000 | +104.9% | 17,100 | +125.0% | 0.00% | – |
| Q4 2020 | $61,000 | +6000.0% | 7,600 | +7500.0% | 0.00% | – |
| Q3 2020 | $1,000 | -91.7% | 100 | -94.4% | 0.00% | – |
| Q2 2020 | $12,000 | -65.7% | 1,800 | -76.6% | 0.00% | – |
| Q1 2020 | $35,000 | -25.5% | 7,700 | 0.0% | 0.00% | – |
| Q4 2019 | $47,000 | – | 7,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |